WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael John SumnerChief Medical Officer2025-05-15680$1.95
$1.33kSell
Laurent HumeauChief Scientific Officer2025-05-151,708$1.95
$3.33kSell
Peter KiesCFO2025-05-152,566$1.95
$5.00kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-157,717$1.95
$15.05kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-102,392$1.80
$4.31kSell
Laurent HumeauChief Scientific Officer2025-02-261,584$1.98
$3.14kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-02-262,493$1.98
$4.94kSell
Peter KiesCFO2025-02-262,960$1.98
$5.86kSell
Laurent HumeauChief Scientific Officer2025-02-262,059$1.98
$4.08kSell
Peter KiesCFO2025-02-262,362$1.98
$4.68kSell

1 of 2

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe38.55%20,650,987$42.75MInsider
Tee Khiang Ng9.15%4,899,931$10.14MInsider
Adage Capital Partners GP LLC6.40%3,428,571$7.10MInstitution
Janus Henderson Group PLC6.10%3,266,260$6.76MInstitution
Vanguard Group Inc5.06%2,712,872$5.62MInstitution
Jong Joseph Kim4.38%2,346,000$4.86MInsider
Boxer Capital Management LLC4.29%2,300,000$4.76MInstitution
Millennium Management LLC3.68%1,972,518$4.08MInstitution
Beng Lee Gan1.54%823,045$1.70MInsider
Renaissance Technologies LLC1.52%816,339$1.69MInstitution

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO38.66%57.97%Net Selling
KLRS4.42%95.58%Net Selling
ABOS58.99%17.23%Net Selling
IKT71.15%28.85%Net BuyingNet Buying
SLGL20.05%13.68%Net BuyingNet Buying
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 38.66% institutional shareholders, 57.97% Inovio Pharmaceuticals insiders, and 3.37% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 38.55% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $42.75M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.